Robert W Postma
Director at Alaunos Therapeutics, Inc. (TCRT) since February 2021
Robert W Postma has filed 15 insider reports with the SEC since March 2021, as director at Alaunos Therapeutics, Inc. (TCRT). Robert W Postma made no open-market purchases or sales in the last 12 months. The latest filing, on July 27, 2026, reports grant or award at Alaunos Therapeutics, Inc. (TCRT).
- Filings
- 15
- Companies
- 1
- Bought on market
- $617K
- Sold on market
- None
Companies where Robert W Postma is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2021 | 58,609 | $617K | $0.75 | $1.66+121% | Jul 27, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jul 23, 2026TCRTDirector Postma Robert W was granted 8,463 shares, increasing direct ownership by 17% to 58,609 unitsForm 4Grant or award
- Apr 29, 2026TCRTDirector Postma Robert W was granted 6,274 shares, increasing direct ownership by 14% to 50,146 unitsForm 4Grant or award
- Jan 12, 2026TCRTDirector Postma Robert W was granted 5,622 shares, increasing direct ownership by 15% to 43,872 unitsForm 4Grant or award
- Nov 21, 2025TCRTDirector Postma Robert W was granted 5,142 shares, increasing direct ownership by 16% to 38,250 unitsForm 4Grant or award
- Jul 3, 2025TCRTDirector Postma Robert W was granted 4,050 shares, increasing direct ownership by 14% to 33,133 unitsForm 4Grant or award
- Jun 24, 2025TCRTDirector Postma Robert W was granted 20,804 shares, increasing direct ownership by 251% to 29,083 unitsForm 4Grant or awardOpen-market purchase
- Apr 13, 2025TCRTDirector Postma Robert W was granted 20,804 shares, increasing direct ownership by 251% to 29,083 unitsForm 4Grant or awardOpen-market purchase
- Jun 6, 2024TCRTSEC Form 4 filed by Director Postma Robert WForm 4Grant or award
- Jun 6, 2023TCRTSEC Form 4 filed by Postma Robert WForm 4Grant or award
- Nov 29, 2022+$488KTCRTSEC Form 4: Postma Robert W bought $487,500 worth of shares (750,000 units at $0.65)Form 4Open-market purchase
- Jun 22, 2022TCRTSEC Form 4: Postma Robert W was granted 40,000 shares, increasing direct ownership by 3% to 1,241,870 unitsForm 4Grant or award
- Jun 22, 2022TCRTSEC Form 4: Postma Robert W was granted 40,000 shares, increasing direct ownership by 3% to 1,241,870 unitsForm 4Grant or award
- Sep 2, 2021+$130KTCRTSEC Form 4: Postma Robert W bought $129,750 worth of Common Stock (75,000 units at $1.73), increasing direct ownership by 2% to 1,201,870 unitsForm 4Open-market purchase
- Mar 4, 2021TCRTSEC Form 4: Postma Robert W was granted 2,500 units of Common Stock, increasing direct ownership by 0.21% to 1,181,362 unitsForm 4Grant or award
- Feb 5, 2021TCRTSEC Form 3: W Robert Postma claimed ownership of 5,377,944 units of Common StockForm 3New insider
Compare Robert W Postma with
- Robert W Postma vs Holger Weis1 shared
- Robert W Postma vs Michael Allen Jerman1 shared
- Robert W Postma vs Jaime Vieser1 shared
- Robert W Postma vs Ferdinand Groenewald1 shared
- Robert W Postma vs Dale Curtis Hogue Jr.1 shared
- Robert W Postma vs Melinda Lackey1 shared
Other insiders at the same companies
- Holger WeisTCRT
- Michael Allen JermanTCRT
- Jaime VieserTCRT
- Ferdinand GroenewaldTCRT
- Dale Curtis Hogue Jr.TCRT
- Melinda LackeyTCRT
Questions about Robert W Postma
- What is Robert W Postma's role at Alaunos Therapeutics, Inc.?
- Robert W Postma reports to the SEC as director at Alaunos Therapeutics, Inc. (TCRT), according to the latest filing on July 27, 2026.
- How many shares does Robert W Postma own?
- After the latest filing that states it, Robert W Postma directly owned 58,609 shares of Alaunos Therapeutics, Inc. (TCRT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert W Postma bought or sold stock recently?
- The most recent open-market purchase was on November 29, 2022: bought 750,000 shares of Alaunos Therapeutics, Inc. (TCRT) for $488K at an average of $0.65.
- How do I get alerts when Robert W Postma files?
- Follow Robert W Postma on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert W Postma (SEC CIK 0001827847). Totals count each trade once, skipping amendments whose original is on file, from Mar 22, 2021 on. View on SEC EDGAR · Get this as JSON